QuiVad

Home / Netherlands / Pharming Group N.V.

Pharming Group N.V.

Short position disclosed on August 12, 2026.

Follow

Evolution of the disclosed total

0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 9.64% on February 25, 2020. The shaded band is the year shown above.

January 23, 2014 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Two Sigma Investments, LP1.59%newAugust 10, 2026
Walleye Capital LLC0.99%newAugust 6, 2026
Citadel Advisors LLC0.90%+0.32 ptAugust 12, 2026
Marshall Wace LLP0.88%+0.39 ptAugust 11, 2026
Capstone Volatility Master (Cayman) Limited0.80%-0.05 ptAugust 12, 2026
D. E. Shaw & Co., L.P.0.76%+0.16 ptAugust 11, 2026
Lazard Asset Management LLC0.60%-0.03 ptAugust 11, 2026
Whitebox Advisors LLC0.58%newJune 3, 2026
Qube Research & Technologies Ltd.0.56%newAugust 12, 2026
Spark Investment Management LLC0.52%newJune 19, 2026

On the other side: the funds that hold Pharming Group N.V. Titelia

History of disclosures

1114 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 31, 2020Woodline Partners0.87%still open
July 31, 2020WorldQuant, LLC0.63%still open
July 30, 2020Linden Advisors LP1.05%still open
July 30, 2020Citadel Advisors LLC1.03%still open
July 30, 2020Woodline Partners0.79%still open
July 29, 2020Citadel Advisors LLC0.90%still open
July 27, 2020Woodline Partners0.60%still open
July 24, 2020Citadel Advisors LLC0.81%still open
July 20, 2020Citadel Advisors LLC0.79%still open
July 20, 2020Woodline Partners0.51%still open
July 16, 2020Pictet Asset Management Limited0.93%still open
July 14, 2020Citadel Advisors LLC0.84%still open
July 7, 2020Citadel Advisors LLC0.71%still open
July 6, 2020Citadel Advisors LLC0.69%still open
June 26, 2020Citadel Advisors LLC0.59%still open
June 16, 2020Citadel Advisors LLC0.60%still open
June 11, 2020Linden Advisors LP1.18%still open
June 9, 2020Citadel Advisors LLC0.53%still open
April 30, 2020Linden Advisors LP1.26%still open
April 30, 2020Citadel Advisors LLC0.37%still open
April 29, 2020Citadel Advisors LLC0.59%still open
April 28, 2020Citadel Advisors LLC0.67%still open
April 21, 2020Linden Advisors LP1.18%still open
April 20, 2020Woodline Partners0.48%still open
April 17, 2020Citadel Advisors LLC0.70%still open
April 16, 2020Citadel Advisors LLC0.62%still open
April 15, 2020Citadel Advisors LLC0.56%still open
March 25, 2020Point72 Asset Management, L.P.0.44%still open
March 24, 2020Woodline Partners0.58%still open
March 23, 2020Point72 Asset Management, L.P.0.60%still open
March 20, 2020Pictet Asset Management Limited0.88%still open
March 19, 2020Woodline Partners0.76%still open
March 18, 2020Pictet Asset Management Limited0.99%still open
March 18, 2020Point72 Asset Management, L.P.0.76%still open
March 17, 2020Woodline Partners0.81%still open
March 17, 2020Kingdon Capital Management LLC0.31%still open
March 16, 2020Point72 Asset Management, L.P.0.88%still open
March 13, 2020Great Point Partners, LLC1.90%still open
March 13, 2020Point72 Asset Management, L.P.0.94%still open
March 13, 2020Woodline Partners0.93%still open
March 13, 2020Kingdon Capital Management LLC0.68%still open
March 12, 2020Pictet Asset Management Limited1.07%still open
March 11, 2020Woodline Partners1.01%still open
March 6, 2020Pictet Asset Management Limited1.19%still open
March 5, 2020Linden Advisors LP1.26%still open
March 3, 2020Linden Advisors LP1.32%still open
March 3, 2020Point72 Asset Management, L.P.1.02%still open
March 2, 2020Linden Advisors LP1.26%still open
February 27, 2020Point72 Asset Management, L.P.0.96%still open
February 26, 2020Linden Advisors LP1.32%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Pharming Group N.V., source AFM, data as at August 12, 2026, https://www.quivad.com/action/pharming-group-n-v?page=17